ArticleCell death and differentiation2021

Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.

Gang Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.